Symrise announced that Heinz-Jürgen Bertram has been appointed to the position of chief executive officer effective July 1, 2009. Bertram succeeds Gerold Linzbach, who, for personal reasons, has not asked for his contract to be renewed when it expires on October 22, 2009.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.
Thermo Fisher Scientific recently announced an expansion of its strategic partnership with Sanofi to enable additional US drug product manufacturing.
Diversity, equity, and inclusion (DE&I) initiatives have become increasingly important for attracting diverse perspectives, improving problem solving and advancing innovation in companies.
